Even though MYC signaling could be identified to play a crucial role in LCSC-like survival, underlying mechanisms involved in this signaling pathway still remain unclear, and MYC-inhibiting drugs have to be clinically approved to be able to use them against NSCLC. Here, MYC is linked to non-small cell lung carcinoma.